Patient-reported quality of life, unmet needs and care coordination outcomes: Moving toward targeted breast cancer survivorship care planning

Asia-Pacific Journal of Clinical Oncology

Volumn 12, Issue 2, 2016, Pages e323-e331

  Brennan, Meagan Elizabeth ^a,b   Butow, Phyllis ^c   Spillane, Andrew John ^a,d   Boyle, Frances ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Mater Hospital   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d Ryde and North Shore Hospitals   (Australia)

Author keywords

breast cancer; follow up care; quality of life; survivorship care plan; unmet need

Indexed keywords

ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; TAMOXIFEN; TRASTUZUMAB;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER CARE COORDINATION; CANCER RECURRENCE; CANCER SURVIVAL; CANCER THERAPY; COHORT ANALYSIS; CONTROLLED STUDY; FEAR; FEMALE; HEALTH CARE NEED; HUMAN; MAJOR CLINICAL STUDY; MEDICAL CARE; PATIENT CARE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SELF REPORT; TREATMENT PLANNING; VERY ELDERLY;

EID: 84991080617     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/ajco.12254     Document Type: Article

References (45)

1. Ganz PA, Ganz PA. Monitoring the physical health of cancer survivors: A survivorship-focused medical history. J Clin Oncol 2006; 24 (32): 5105–5111.
2. Ganz PA, Guadagnoli E, Landrum MB, Lash TL, Rakowski W, Silliman RA. Breast cancer in older women: Quality of life and psychosocial adjustment in the 15 months after diagnosis. J Clin Oncol 2003; 21 (21): 4027–4033.
3. Hewitt M, Greenfield S, Stovall E, eds. From Cancer Patient to Cancer Survivor: Lost in Transition. National Academy Press, Washington, DC 2006. Committee on Cancer Survivorship: Improving Care and Quality of Life, National Cancer Policy Board, eds.
4. Brennan ME, Butow P, Spillane AJ, Marven M, Boyle FM. Follow-up after breast cancer–Views of Australian women. Aust Fam Physician 2011; 40 (5): 311–316.
5. American Society of Clinical Oncology, Cancer.Net. ASCO Cancer Treatment Summaries. 2013; [cited April 2013], Available from URL: http://www.cancer.net/survivorship/asco-cancer-treatment-summaries.
6. Earle CC. Failing to plan is planning to fail: Improving the quality of care with survivorship care plans. J Clin Oncol 2006; 24 (32): 5112–5116.
7. Ganz PA, Hahn EE. Implementing a survivorship care plan for patients with breast cancer. J Clin Oncol 2008; 26 (5): 759–767.
8. Khatcheressian JL, Hurley P, Bantung E et al. Breast cancer follow-up and management after primary treatment: American society of clinical oncology clinical practice guideline update. J Clin Oncol 2013; 31 (7): 961–965.
9. Khatcheressian JL, Wolff AC, Smith TJ et al. American society of clinical oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 2006; 5091–5097.
10. Ganz PA, Rowland JH, Desmond KA. Life after breast cancer: Understanding women's health-related quality of life and sexual functioning. J Clin Oncol 1998; 16 (2): 501–514.
11. Fallowfield LJ, Leaity SK, Howell A, Benson S, Cella D. Assessment of quality of life in women undergoing hormonal therapy for breast cancer: Validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat 1999; 55: 189–199.
12. Rosenberg SM, Partridge AH. Premature menopause in young breast cancer: Effects on quality of life and treatment interventions. J Thorac Dis 2013; 5 (Suppl 1): S55–61.
13. Härtl K, Janni W, Kästner R et al. Impact of medical and demographic factors on long-term quality of life and body image of breast cancer patients. Ann Oncol 2003; 14 (7): 1064–1071.
14. Brady MJ, Cella DF, Mo F et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Breastquality-of-life instrument. J Clin Oncol 1997; 15 (3): 974–986.
15. Cella D, Fallowfield L, Barker P, Cuzick J, Locker G, Howell A. Quality of life of postmenopausal women in the ATAC (“ ‘Arimidex' ”, tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer. Breast Cancer Res Treat 2006; 100: 273–284.
16. Chopra I, Kamal KM. A systematic review of quality of life instruments in long-term breast cancer survivors. Health Qual Life Outcomes 2012; 10: 14.
17. Hodgkinson K, Butow P, Hunt GE et al. The development and evaluation of a measure to assess cancer survivors' unmet supportive care needs: The CaSUN (Cancer Survivors' Unmet Needs measure). Psychooncology 2007; 16: 796–804.
18. Smith AB, King M, Butow P et al. The prevalence and correlates of supportive care needs in testicular cancer survivors: a cross-sectional study. Psychooncology 2013; 22 (11) 2557–2564.
19. Grunfeld E, Fitzpatrick R, Mant D et al. Comparison of breast cancer patient satisfaction with follow-up in primary care versus specialist care: Results from a randomized controlled trial. Br J Gen Pract 1999; 49 (446): 705–710.
20. Young JM, Walsh J, Butow PN, Solomon MJ, Shaw J. Measuring cancer care coordination: Development and validation of a questionnaire for patients. BMC Cancer 2011; 11: 298.
21. IBM Corporation. IBM SPSS Statistics 21.0. IBM, Armonk, New York, USA, 2012.
22. Australian Institute of Health and Welfare (AIHW), Cancer Australia. Breast Cancer in Australia: An Overview. AIHW, Canberra 2012. Vol Cancer Series No. 71. Cat. No. CAN 67.
23. Fallowfield L, Cella D, Cuzick J, Francis S, Locker G, Howell A. Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) adjuvant breast cancer trial. J Clin Oncol 2004; 22 (21): 4261–4271.
24. Fallowfield LJ, Bliss JM, Porter LS et al. Quality of life in the intergroup exemestane study: A randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancer. J Clin Oncol 2006; 24 (6): 910–917.
25. Fallowfield LJ, Kilburn LS, Langridge C et al. Long-term assessment of quality of life in the Intergroup Exemestane Study: 5 years post-randomisation. Br J Cancer 2012; 106 (6): 1062–1067.
26. van Nes JG, Fontein DB, Hille ET et al. Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: A Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study. Breast Cancer Res Treat 2012; 134 (1): 267–276.
27. Hodgkinson K, Butow P, Hunt GE, Pendlebury S, Hobbs KM, Wain G. Breast cancer survivors' supportive care needs 2–10 years after diagnosis. Support Care Cancer 2007; 15: 515–523.
28. Hodgkinson K, Butow P, Fuchs A et al. Long-term survival from gynecologic cancer: Psychosocial outcomes, supportive care needs and positive outcomes. Gynecol Oncol 2007; 104 (2): 381–389.
29. Urbaniec OA, Collins K, Denson LA, Whitford HS. Gynecological cancer survivors: Assessment of psychological distress and unmet supportive care needs. J Psychosoc Oncol 2011; 29 (5): 534–551.
30. Bender JL, Wiljer D, To MJ et al. Testicular cancer survivors' supportive care needs and use of online support: A cross-sectional sur-vey. Support Care Cancer 2012; 20 (11): 2737–2746.
31. Harrison SE, Watson EK, Ward AM et al. Primary health and supportive care needs of long-term cancer survivors: A questionnaire survey. J Clin Oncol 2011; 29 (15): 2091–2098.
32. Simard S, Thewes B, Humphris G et al. Fear of cancer recurrence in adult cancer survivors: A systematic review of quantitative studies. J Cancer Surviv 2013; 7: 300–322.
33. Crist J, Grunfeld E. Factors reported to influence fear of cancer recurrence in cancer patients: A systematic review. Psychooncology 2012; 22 (5): 978–986.
34. Thewes B, Bell ML, Butow P et al. Psychological morbidity and stress but not social factors influence level of fear of cancer recurrence in young women with early breast cancer: Results of a cross-sectional study. Psychooncolgy 2013; 22 (12): 2797–2806.
35. Wiggers JH, Donovan KO, Redman S, Sanson-Fisher RW. Cancer patient satisfaction with care. Cancer 1990; 66: 610–616.
36. Howard-Anderson J, Ganz PA, Bower JE, Stanton AL. Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: A systematic review. J Natl Cancer Inst 2012; 104: 186–405.
37. Partridge AH. Ovarian suppression for prevention of premature menopause and infertility: Empty promise or effective therapy? J Clin Oncol 2012; 30 (5): 479–481.
38. Blinder VS, Norris VW, Peacock NW et al. Patient perspectives on breast cancer treatment plan and summary documents in community oncology care. Cancer 2013; 119 (1): 164–172.
39. Grunfeld E, Julian JA, Pond G et al. Evaluating survivorship care plans: Results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol 2011; 29 (36): 4755–4762.
40. Miller R. Implementing a survivorship care plan for patients with breast cancer. Clin J Oncol Nurs 2008; 12 (3): 479–487.
41. Blaauwbroek R, Barf HA, Groenier KH et al. Family doctor-driven follow-up for adult childhood cancer survivors supported by a web-based survivor care plan. J Cancer Surviv 2012; 6 (2): 163–171.
42. Brothers BM, Easley A, Salani R, Aanndersen BL. Do survivorship care plans impact patients' evaluations of care? A randomized evaluation with gynecologic oncology patients. Gynecol Oncol 2013; 129 (3): 554–558.
43. Oeffinger KC, Hudson MM, Mertens AC et al. Increasing rates of breast cancer and cardiac surveillance among high-risk survivors of childhood Hodgkin lymphoma following a mailed, one-page survivorship care plan. Pediatr Blood Cancer 2011; 56 (5): 818–824.
44. Spain PD, Oeffinger KC, Candela J, McCabe M, Ma X, Tonorezos ES. Response to a treatment summary and care plan among adult survivors of pediatric and young adult cancer. J Oncol Pract 2012; 8 (3): 196–201.
45. Livestrong Foundation. Livestrong care plan. [Cited 13 June 2014.] Available from URL: http://www.livestrongcareplan.org/.